Address: #306 – 2309 West 41st Avenue Vancouver BC V6M 2A3 Canada
Phone:604.605-0507 Fax: (604) 605-0508
Member Sector: Medical Devices
Verisante Technology, Inc. is committed to helping save lives through the development of innovative systems for the early detection of cancer. The Company’s initial focus is skin cancer, including basal cell carcinoma, squamous cell carcinoma, and melanoma. The Company has licensed a technology developed by the BC Cancer Agency for in vivo, real-time, non-invasive skin measurements. This platform technology may also be applied to early detection systems for other types of cancer, including lung, GI, colorectal, and cervical cancers.